Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04303000 · ClinicalTrials.gov registry record · Phase 4
Increasing Naloxone Access for Persons Who Use Opioids
A Phase 4 study, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- Phase 4
- Development phase
- 111
- Enrollment target
NCT04303000 is a Phase 4 study that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 111 participants.
The verdict
NCT04303000, a Phase 4 study, has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 111 participants
- Enrollment target
Study Summary
Deaths relating to opioid overdose have rapidly increased over the past two decades. Due to the serious public health concern of the opioid epidemic, federal agencies recommend employing various harm reduction interventions. The implementation of Opioid Overdose Education and Naloxone Distribution (OEND) programs is effective in reducing opioid overdose mortality, yet these programs do not reach many high-risk individuals. Traditionally, OEND program venues are found in large, urban medical centers, drug treatment facilities, and needle exchange programs. Identifying unreached, high-risk individuals and providing training and naloxone kits through online recruitment could significantly expand access to this life-saving intervention. The primary goal of the current proposed project is to examine the acceptability and feasibility of online recruitment, online opioid overdose and naloxone administration education, and postal distribution of naloxone kits.
Interventions
- DRUG Opioid Overdose Education with Naloxone Distribution
- DRUG Opioid Overdose Education
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 111 participants |
| Start Date | 2021-07-11 |
| Est. Completion | 2022-01-13 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04303000
The ClinicalTrials.gov registry entry for NCT04303000 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 111 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Opioid Overdose Education with Naloxone Distribution is the first listed.
NCT04303000 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04303000 about?
NCT04303000 is a clinical study titled "Increasing Naloxone Access for Persons Who Use Opioids". Deaths relating to opioid overdose have rapidly increased over the past two decades. Due to the serious public health concern of the opioid epidemic, federal agencies recommend employing various harm reduction interventions. The implementation of Opioid Overdose Education and Naloxone Distribution (...
What is the current status of trial NCT04303000?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 111 participants. The study started on 2021-07-11. Estimated completion is 2022-01-13.
What interventions are being tested in trial NCT04303000?
The interventions under investigation include: Opioid Overdose Education with Naloxone Distribution (DRUG), Opioid Overdose Education (DRUG).
Who is sponsoring clinical trial NCT04303000?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.